ZTT-66875-45385
3 vaccinations
6 coded responses
38 check-ins
6 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 41-45
- ZIP prefix
- 152 / PA
- Registered
- 2021-03-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-01
Registered in v-safe
-
2021-03-04
Dose 1 — Pfizer-BioNTech
- 2021-03-04
- 2021-03-05
- 2021-03-06
-
2021-03-07
Survey response — days 1–6 daily, dose 1MedDRA: Irritable bowel syndrome, Pre-existing disease — Feeling: Fair · Abdominal painFree text: Constipation that is related to IBS-C.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-08
- 2021-03-09
- 2021-03-10
-
2021-03-11
Survey response — day 7, dose 1MedDRA: Nausea, Pre-existing disease — Feeling: Good · NauseaFree text: I have IBS-C, for which I take medication that occasionally makes me nauseous.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-18
-
2021-03-25
Dose 2 — Pfizer-BioNTech
- 2021-03-25
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Chills, Joint pains, Fatigue or tirednessAdult check-in
- 2021-03-28
- 2021-03-29
- 2021-03-30
-
2021-03-31
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease — Feeling: Fair · ChillsFree text: IBS-related symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
- 2021-04-08
- 2021-04-15
-
2021-04-22
Survey response — day 28, dose 2MedDRA: Facial pain, Irritable bowel syndrome, Nausea, Sinus pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Nausea; sinus and facial pain. Nausea is likely connected to the medications I take for a chronic condition, IBS-C. As a person who suffers regularly from allergies, especially the start of spring, the sinus/facial pain will likely be fleeting.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-29
-
2021-05-06
Survey response — day 42, dose 2MedDRA: Gastrointestinal disorder, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: GI issues related to IBS-C.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-06
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-24
-
2021-08-19
Dose 3 — Pfizer-BioNTech
- 2021-08-20
- 2021-08-21
- 2021-08-22
- 2021-08-23
- 2021-08-24
- 2021-08-25
- 2021-08-26
- 2021-09-02
- 2021-09-09
- 2021-09-16
- 2021-09-23
- 2021-09-30
-
2021-11-18
Survey response — 3 months, dose 3MedDRA: Influenza like illness — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Flu-like symptoms. Subsequently, a PCR test returned negative.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-18
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-19
-
2021-11-19
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-02-17
- 2022-08-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-03-25 | Pfizer-BioNTech | |
| 3 | 2021-08-19 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-06 | Successful | Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2021-11-18 | Successful 2021-11-19 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Constipation that is related to IBS-C.
Release 5 — day 7, dose 1
Systemic reaction (other): I have IBS-C, for which I take medication that occasionally makes me nauseous.
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): IBS-related symptoms
Release 7 — day 28, dose 2
Symptoms: Nausea; sinus and facial pain. Nausea is likely connected to the medications I take for a chronic condition, IBS-C. As a person who suffers regularly from allergies, especially the start of spring, the sinus/facial pain will likely be fleeting.
Release 8 — day 42, dose 2
Symptoms: GI issues related to IBS-C.
Release 10 — 3 months, dose 3
Symptoms: Flu-like symptoms. Subsequently, a PCR test returned negative.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Facial pain | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | ✓ | ✓ | ✓ |
| SD | Influenza like illness | · | · | ✓ |
| SD | Irritable bowel syndrome | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Sinus pain | ✓ | ✓ | ✓ |
| SRO | Irritable bowel syndrome | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release